Evidence map›Paper›PMID 28941979›Full record

ArticleThe American journal of pathology2017

Proteolytic Degradation and Inflammation Play Critical Roles in Polypoidal Choroidal Vasculopathy.

Sandeep Kumar, Hiroyuki Nakashizuka, Alex Jones, Alyssia Lambert, Xuchen Zhao, Megan Shen, Mackenzie Parker, Shixian Wang, Zachary Berriochoa, Amrita Fnu and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. The hypothetical molecular mechanism of the ethnic variations in the manifestation of age-related macular degeneration; focuses on the functions of the most significant susceptibility genes.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. International journal of molecular sciences · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Sandeep KumarDepartment of Ophthalmology, Baylor College of Medicine, Houston, Texas.
Hiroyuki NakashizukaDepartment of Visual Sciences, Nihon University School of Medicine, Tokyo, Japan.
Alex JonesDepartment of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, Utah.
Alyssia LambertDepartment of Chemistry, University of Utah, Salt Lake City, Utah.
Xuchen ZhaoDepartment of Chemistry, University of Utah, Salt Lake City, Utah.
Megan ShenDepartment of Ophthalmology, Baylor College of Medicine, Houston, Texas.
Mackenzie ParkerDepartment of Ophthalmology, Baylor College of Medicine, Houston, Texas.
Shixian WangDepartment of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, Utah.
Zachary BerriochoaDepartment of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, Utah.
Amrita FnuDepartment of Ophthalmology, Baylor College of Medicine, Houston, Texas.
Stephanie VanBeugeDepartment of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, Utah.
Patricia Chévez-BarriosDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.
Mark TsoWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jon RainierDepartment of Chemistry, University of Utah, Salt Lake City, Utah.
Yingbin FuDepartment of Ophthalmology, Baylor College of Medicine, Houston, Texas; Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, Utah. Electronic address: yingbin.fu@bcm.edu.
University of Utah · USBaylor College of Medicine · USJohns Hopkins University · USMethodist Hospital · USNihon University · JP

Funding

VISION RESEARCH CENTERP30EY002520 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$14.8M
University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI PAUL STEVEN BERNSTEIN · 2005 to 2026
$14.6M
Mechanisms and treatment strategies for polypoidal choroidal vasculopathR01EY022901 · NEI · UNIVERSITY OF UTAH · PI FU, YINGBIN · 2014 to 2016
$1.3M
NEI NIH HHS P30 EY002520NEI NIH HHS P30 EY014800NEI NIH HHS R01 EY022901
6 · The paper itself

Abstract

Polypoidal choroidal vasculopathy (PCV) is a common subtype of wet age-related macular degeneration in Asian populations, whereas choroidal neovascularization is the typical subtype in Western populations. The cause of PCV is unknown. By comparing the phenotype of a PCV mouse model expressing protease high temperature requirement factor A1 (HTRA1) in retinal pigment epithelium with transgenic mice expressing the inactive HTRA1

Indexed as

AgedAged, 80 and overAnimalsChoroidal NeovascularizationFemaleHigh-Temperature Requirement A Serine Peptidase 1HumansInflammationMacular DegenerationMaleMiceMice, TransgenicMiddle AgedProteolysisWet Macular DegenerationHigh-Temperature Requirement A Serine Peptidase 1HTRA1 protein, human

Identifiers

PMID28941979
PMCPMC5718105
OpenAlexW2759649892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.